New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For EXPR;QCOR;GGC;ADTN;MDRX From The Last 14 Days
Check below for free stories on EXPR;QCOR;GGC;ADTN;MDRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
July 11, 2014
09:09 EDTQCOROn The Fly: Pre-market Movers
Subscribe for More Information
06:39 EDTQCORQuestcor reports Acthar adverse effects data, NY Times says
The number of patients who reported an adverse effect last year while taking Questcor's (QCOR) Acthar drug amounted to almost 5% of prescriptions dispensed, the company stated in a regulatory filing released yesterday, according to The New York Times. The filing marked the first time that the company has disclosed any difficulties experienced by Acthar patients, the newspaper added. Questcor has agreed to be bought by Mallinckrodt (MNK). Reference Link
July 10, 2014
13:41 EDTMDRXAllscripts climbs after acquisition, upgrade
Subscribe for More Information
10:05 EDTMDRXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:50 EDTMDRXAllscripts upgraded at ISI Group
Subscribe for More Information
06:30 EDTMDRXAllscripts upgraded to Strong Buy from Buy at ISI Group
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use